|Articles|August 10, 2015
CRF Health Unveils TrialMax ConMed™ for Oncology Trials
The identification of concomitant medication poses specific challenges in oncology data reporting.
Advertisement
CRF Health, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions introduced a complete TrialMax® eCOA solution specifically for oncology clinical trials. The identification of concomitant medication poses specific challenges in oncology data reporting. To address this, CRF Health has incorporated its new TrialMax ConMed™ solution into the platform, allowing patients to report concomitant medication taken during a trial in real-time.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement